Study Shows AI-CVD® Outperforms Diabetes in Predicting Heart Failure Risk HOUSTON, TX, May 18, 2026 - HeartLung Corporation announced the publication...
HeartLung.AI Emerges as a Leading Innovator in Cardiology with 10 Accepted ESC.26 Abstracts Accepted studies highlight HeartLung.AI’s scientific leadership in...
Arthur Agatston, MD, FACC*, discusses: --The role of HDL and HDL-C in atherosclerotic cardiovascular diseases. --What influence does HDL dysfunction...